Knight Therapeutics Inc. (TSX:GUD)
Canada · Delayed Price · Currency is CAD 9.84
+0.07 (0.72%)
Jul 31, 2026, 4:00 PM EST
Knight Therapeutics Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 510.45 | 450.09 | 371.3 | 328.2 | 293.56 | 243.48 |
Revenue Growth | 36.93% | 21.22% | 13.13% | 11.80% | 20.57% | 22.03% |
Gross Profit Gross Profit Growth | 234.47 | 200.23 | 174.41 | 152.65 | 138.06 | 115.41 |
Operating Income Operating Income Growth | -3.67 | -2.35 | 7.4 | -2.89 | -41.04 | -12.83 |
Net Income Net Income Growth | -3.24 | -5.37 | 4.33 | -16.84 | -29.89 | -15.68 |
Earnings Per Share EPS Growth | 0.05 | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 |
EPS Growth | 1437.67% | - | - | - | - | -59.38% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 114.87 | 84.28 | 25.69 | 19.67 | 11.35 | 7.7 |
Brazil Brazil Growth | 203.05 | 182.52 | 180.63 | 168.22 | 134.73 | 97.2 |
Argentina Argentina Growth | 43.91 | 40.75 | 45.9 | 24.1 | 46.13 | 42.96 |
Colombia Colombia Growth | 57.57 | 55 | 51.48 | 44.63 | 48.15 | 43.52 |
Mexico Mexico Growth | 27.33 | 24.5 | 18.99 | 15.89 | - | - |
Rest of The Latin America Rest of The Latin America Growth | 41.98 | 43.02 | 38.83 | 39.22 | 40.17 | 40.95 |
Other Other Growth | 21.75 | 20.02 | 9.78 | 16.48 | 13.05 | 11.15 |
Total Total Growth | 510.45 | 450.09 | 371.3 | 328.2 | 293.56 | 243.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 127.29 | 95.28 | 142.33 | 154.42 | 157.51 | 149.5 |
Total Debt Total Debt Growth | 69.78 | 77.91 | 49.46 | 69.09 | 77.7 | 40.96 |
Net Cash (Debt) Net Cash Growth | 57.52 | 17.37 | 92.87 | 85.33 | 79.81 | 108.54 |
Net Cash Growth | -34.33% | -81.30% | 8.84% | 6.92% | -26.48% | -66.16% |
Net Cash Per Share Net Cash Per Share Growth | 0.58 | 0.17 | 0.92 | 0.79 | 0.69 | 0.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 105.98 | 68.96 | 36.28 | 35.94 | 45 | 44.62 |
Capital Expenditures CapEx Growth | -4.86 | -1.91 | -2.47 | -0.95 | -2.89 | -3.83 |
Free Cash Flow Free Cash Flow Growth | 101.12 | 67.05 | 33.81 | 34.99 | 42.12 | 40.79 |
Free Cash Flow Growth | 1329.46% | 98.30% | -3.37% | -16.92% | 3.26% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.93% | 44.49% | 46.97% | 46.51% | 47.03% | 47.40% |
Operating Margin | -0.72% | -0.52% | 1.99% | -0.88% | -13.98% | -5.27% |
Pretax Margin | 1.54% | -1.49% | 0.55% | -6.70% | -14.97% | 2.75% |
Profit Margin | -0.64% | -1.19% | 1.17% | -5.13% | -10.18% | -6.44% |
FCF Margin | 19.81% | 14.90% | 9.11% | 10.66% | 14.35% | 16.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 172.88 | - | 133.50 | - | - | 40.77 |
Forward PE | 95.78 | 201.67 | 157.06 | 79.24 | 95.37 | 82.43 |
P/FCF Ratio | 9.49 | 8.95 | 15.80 | 15.01 | 13.80 | 15.31 |
PS Ratio | 1.88 | 1.33 | 1.44 | 1.60 | 1.98 | 2.56 |